SCHEMBL1032617

SCHEMBL1032617

CN(C)P(=O)(O)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL27919110 0.80
SCHEMBL11046791 0.76
SCHEMBL11053145 0.75
SCHEMBL4914754 0.75
SCHEMBL3270647 0.75
Hydrochloric Acid SCHEMBL11586598 0.72 CA2 (0.43)
SCHEMBL13303865 0.72
SCHEMBL113460 0.72
Hydrochloric Acid SCHEMBL11584278 0.72
Hydrochloric Acid SCHEMBL8982942 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12076391-B2 Method for adapting influenza viruses to Vero cells YISHENG BIOPHARMA (SINGAPORE) PTE LTD (SG) 2024-09-03 US claimed
US-20230310578-A1 METHOD FOR ADAPTING INFLUENZA VIRUSES TO VERO CELLS LAKESHORE BIOPHARMA (SINGAPORE) PTE. LTD. (SG) 2023-10-05 US claimed
US-11690909-B2 Composition for treating and/or preventing Hepatitis B virus infection and the use thereof YISHENG BIOPHARMA (SINGAPORE) PTE LTD (SG) 2023-07-04 US claimed
US-11612648-B2 Method for adapting influenza viruses to Vero cells YISHENG BIOPHARMA (SINGAPORE) PTE LTD (SG) 2023-03-28 US claimed
US-20220211840-A1 COMPOSITION FOR TREATING AND/OR PREVENTING HEPATITIS B VIRUS INFECTION AND THE USE THEREOF LAKESHORE BIOPHARMA (SINGAPORE) PTE. LTD. (SG) 2022-07-07 US claimed
EP-0828421-B1 Synergistic insecticidal mixtures based on chloronicotinyl insecticides BAYER CROPSCIENCE AG (DE) 2006-04-26 EP claimed
EP-0828421-A1 INSECTICIDES BAYER AG (DE) 1998-03-18 EP claimed
WO-1996037105-A1 INSECTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1996-11-28 WO claimed
EP-4551580-A2 CRYSTALLINE MONOMERS FOR PREPARING ANTISENSE OLIGONUCLEOTIDES AND METHODS OF THEIR PREPARATION AND USE Eisai R&D Management Co., Ltd. (JP) 2025-05-14 EP disclosed
US-12076391-B2 Method for adapting influenza viruses to Vero cells YISHENG BIOPHARMA (SINGAPORE) PTE LTD (SG) 2024-09-03 US disclosed
WO-2024010870-A2 CRYSTALLINE MONOMERS FOR PREPARING ANTISENSE OLIGONUCLEOTIDES AND METHODS OF THEIR PREPARATION AND USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-01-11 WO disclosed
US-20230310578-A1 METHOD FOR ADAPTING INFLUENZA VIRUSES TO VERO CELLS LAKESHORE BIOPHARMA (SINGAPORE) PTE. LTD. (SG) 2023-10-05 US disclosed
US-11612648-B2 Method for adapting influenza viruses to Vero cells YISHENG BIOPHARMA (SINGAPORE) PTE LTD (SG) 2023-03-28 US disclosed
EP-3383181-A2 ENHANCER COMPOSITIONS FOR AGRICULTURAL CHEMICALS AND AGRICULTURAL CHEMICAL COMPOSITIONS Ibex Bionomics LLC (US) 2018-10-10 EP disclosed
US-20090099135-A1 Pest control compositions and methods TYRATECH, INC. (US) 2009-04-16 US disclosed
EP-2035032-A2 METHODS FOR ESTER DETOXICATION Human Biomolecular Research Institute (US) 2009-03-18 EP disclosed
WO-2007146003-A2 METHODS FOR ESTER DETOXICATION HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) 2007-12-21 WO disclosed
US-20070286846-A1 Novel methods for ester detoxication HUMAN BIOMOLECULAR RESEARCH INSTITUTE 2007-12-13 US disclosed
EP-0828421-B1 Synergistic insecticidal mixtures based on chloronicotinyl insecticides BAYER CROPSCIENCE AG (DE) 2006-04-26 EP disclosed
US-20020173473-A1 Organic compounds GOEBEL THOMAS (DE) 2002-11-21 US disclosed